Articles tagged with “IV ketamine”
A clinical trial participant describes a ketamine infusion, per a September 2026 report. Here's what the account reveals and what remains unverified.
NRx Pharmaceuticals signals FDA review progress on its preservative-free ketamine application. What this means for patients and clinicians in 2026.
Send corrections, provider questions, or advertising inquiries.
